Nov 16 (Reuters) - Medicenna Therapeutics Corp MDNA.TO
* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology
Nov 16 (Reuters) - Medicenna Therapeutics Corp MDNA.TO
* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology